{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:49:50Z","timestamp":1791348590581,"version":"4.3.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001459","name":"Ministry of Education - Singapore","doi-asserted-by":"publisher","award":["AcRF Tier 1 Fund RG4\/24"],"award-info":[{"award-number":["AcRF Tier 1 Fund RG4\/24"]}],"id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.xphs.2026.104515","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:43:47Z","timestamp":1790264627000},"page":"104515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oral tablets of therapeutic eutectic solvent prepared by spray immobilization into excipient microparticles and direct compression"],"prefix":"10.1016","volume":"115","author":[{"given":"Eng Hui","family":"Teo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cha Yong","family":"Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wean Sin","family":"Cheow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4358-1939","authenticated-orcid":false,"given":"Kunn","family":"Hadinoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.xphs.2026.104515_bib0001","doi-asserted-by":"crossref","first-page":"9013","DOI":"10.3390\/ijms23169013","article-title":"The relevance of crystal forms in the pharmaceutical field: sword of Damocles or innovation tools?","volume":"23","author":"Braga","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xphs.2026.104515_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114513","article-title":"Pharmaceutical approaches for enhancing solubility and oral bioavailability of poorly soluble drugs","volume":"204","author":"Nyamba","year":"2024","journal-title":"Eur J Pharmaceut Biopharmaceut"},{"issue":"1","key":"10.1016\/j.xphs.2026.104515_bib0003","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1021\/acs.cgd.3c00199","article-title":"An overview on polymorph preparation methods of active pharmaceutical ingredients","volume":"24","author":"Zhou","year":"2024","journal-title":"Cryst Growth Des"},{"key":"10.1016\/j.xphs.2026.104515_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121320","article-title":"Recent advances in drug polymorphs: aspects of pharmaceutical properties and selective crystallization","volume":"611","author":"Shi","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104515_bib0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.fluid.2017.05.009","article-title":"Liquid pharmaceuticals formulation by eutectic formation","volume":"448","author":"Abbott","year":"2017","journal-title":"Fluid Phase Equilib"},{"issue":"15","key":"10.1016\/j.xphs.2026.104515_bib0006","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1021\/acs.cgd.4c00617","article-title":"Revealing the solubility enhancement of active pharmaceutical ingredients through eutectic mixtures formation: a parameter study","volume":"24","author":"Nasrallah","year":"2024","journal-title":"Cryst Growth Des"},{"issue":"3","key":"10.1016\/j.xphs.2026.104515_bib0007","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3390\/pharmaceutics17030300","article-title":"An overview on the role of ionic liquids and deep eutectic solvents in oral pharmaceuticals","volume":"17","author":"Sangiorgi","year":"2025","journal-title":"Pharmaceutics"},{"issue":"20","key":"10.1016\/j.xphs.2026.104515_bib0008","doi-asserted-by":"crossref","first-page":"11894","DOI":"10.1021\/acs.chemrev.3c00384","article-title":"Ionic liquids: new forms of active pharmaceutical ingredients with unique, tunable properties","volume":"123","author":"Shamshina","year":"2023","journal-title":"Chem Rev"},{"key":"10.1016\/j.xphs.2026.104515_bib0009","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejpb.2023.03.002","article-title":"Therapeutic deep eutectic solvents: a comprehensive review of their thermodynamics, microstructure and drug delivery applications","volume":"186","author":"Abdelquader","year":"2023","journal-title":"Eur J Pharmaceut Biopharmaceut"},{"key":"10.1016\/j.xphs.2026.104515_bib0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cogsc.2019.09.004","article-title":"Deep eutectic solvents and their applications as green solvents","volume":"21","author":"Perna","year":"2020","journal-title":"Curr Opin Green Sustain Chem"},{"issue":"5","key":"10.1016\/j.xphs.2026.104515_bib0011","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/03639045.2024.2345131","article-title":"Eutectic solutions for healing: a comprehensive review on therapeutic deep eutectic solvents (TheDES)","volume":"50","author":"Kalantri","year":"2024","journal-title":"Drug Dev Ind Pharm"},{"issue":"10","key":"10.1016\/j.xphs.2026.104515_bib0012","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s11095-022-03322-x","article-title":"Recent developments in ionic liquid-assisted topical and transdermal drug delivery","volume":"39","author":"Md Korban","year":"2022","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2026.104515_bib0013","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.apsb.2025.11.036","article-title":"Advanced oral drug delivery systems: current challenges and emerging technologies","volume":"16","author":"Onoue","year":"2026","journal-title":"Acta Pharmaceut Sin B"},{"issue":"9","key":"10.1016\/j.xphs.2026.104515_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104109","article-title":"Ionic liquid-based formulation approaches for enhanced transmucosal drug delivery","volume":"29","author":"Khan","year":"2024","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.xphs.2026.104515_bib0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.partic.2025.06.008","article-title":"Effects of alginate inclusion on quality attributes and storage stability of gelatin oral pellets encapsulating ionic liquid salt of active pharmaceutical ingredient","volume":"104","author":"Ng","year":"2025","journal-title":"Particuology"},{"issue":"9","key":"10.1016\/j.xphs.2026.104515_bib0016","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1021\/acs.molpharmaceut.0c00467","article-title":"Spray encapsulation as a formulation strategy for drug-based room temperature ionic liquids: exploiting drug\u2013Polymer immiscibility to enable processing for solid dosage forms","volume":"17","author":"Stocker","year":"2020","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2026.104515_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124878","article-title":"Development of polymer-encapsulated microparticles of a lipophilic API-IL and its lipid based formulations for enhanced solubilisation","volume":"667","author":"Tsolaki","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104515_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120669","article-title":"Formulation of ionic liquid APIs via spray drying processes to enable conversion into single and two-phase solid forms","volume":"603","author":"Tsolaki","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104515_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.powtec.2025.120931","article-title":"A fluidised bed particle engineering approach for simultaneous encapsulation and granulation of an API-based ionic liquid","volume":"457","author":"Stocker","year":"2025","journal-title":"Powder Technol"},{"key":"10.1016\/j.xphs.2026.104515_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113840","article-title":"A review of emerging technologies enabling improved solid oral dosage form manufacturing and processing","volume":"178","author":"Sohail Arshad","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2026.104515_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125133","article-title":"Novel therapeutic deep eutectic solvents based on mirtazapine and medium-chain fatty acids for enhancing the transdermal delivery of mirtazapine","volume":"670","author":"He","year":"2025","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2026.104515_bib0022","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/pharmaceutics16050687","article-title":"Formulation of ascorbic acid and betaine-based therapeutic deep eutectic system for enhanced transdermal delivery of ascorbic acid","volume":"16","author":"Song","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104515_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124267","article-title":"Harnessing therapeutic deep eutectic solvents in self-emulsifying systems to improve CBD delivery","volume":"659","author":"Balenzano","year":"2024","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2026.104515_bib0024","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.3390\/pharmaceutics15061710","article-title":"Co-amorphous versus deep eutectic solvents formulations for transdermal administration","volume":"15","author":"Guinet","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104515_bib0025","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejpb.2017.02.003","article-title":"A comparison between pure active pharmaceutical ingredients and therapeutic deep eutectic solvents: solubility and permeability studies","volume":"114","author":"Duarte","year":"2017","journal-title":"Eur J Pharmaceut Biopharmaceut"},{"key":"10.1016\/j.xphs.2026.104515_bib0026","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejpb.2022.04.008","article-title":"Selective terpene based therapeutic deep eutectic systems against colorectal cancer","volume":"175","author":"Pereira","year":"2022","journal-title":"Eur J Pharmaceut Biopharmaceut"},{"issue":"8","key":"10.1016\/j.xphs.2026.104515_bib0027","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3390\/pharmaceutics17080979","article-title":"Exploring ibuprofen\u2013menthol eutectic systems: physicochemical properties and cytotoxicity for pharmaceutical applications","volume":"17","author":"Werner","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104515_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.crchbi.2021.100003","article-title":"Untangling the bioactive properties of therapeutic deep eutectic solvents based on natural terpenes","volume":"1","author":"Silva","year":"2021","journal-title":"Curr Res Chem Biol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104515_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/5525879","article-title":"Microencapsulation of essential oils by spray-drying and influencing factors","volume":"2021","author":"Nguyen","year":"2021","journal-title":"J Food Qual"},{"issue":"1","key":"10.1016\/j.xphs.2026.104515_bib0030","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejpb.2011.08.001","article-title":"Enhancement of griseofulvin release from liquisolid compacts","volume":"80","author":"Hentzschel","year":"2012","journal-title":"Eur J Pharmaceut Biopharmaceut"},{"issue":"5","key":"10.1016\/j.xphs.2026.104515_bib0031","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.apsb.2012.07.005","article-title":"Use of the liquisolid compact technique for improvement of the dissolution rate of valsartan","volume":"2","author":"Chella","year":"2012","journal-title":"Acta Pharmaceut Sin B"},{"key":"10.1016\/j.xphs.2026.104515_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124454","article-title":"A systematic comparison of four pharmacopoeial methods for measuring powder flowability","volume":"661","author":"Tharanon","year":"2024","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2026.104515_bib0033","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/bmc.131","article-title":"Analysis of menthol in three traditional Chinese medicinal herbs and their compound formulation by GC-MS","volume":"16","author":"Lin","year":"2002","journal-title":"Biomed Chromatogr"},{"issue":"11","key":"10.1016\/j.xphs.2026.104515_bib0034","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.3390\/pharmaceutics14112324","article-title":"Drug stability: ICH versus accelerated predictive stability studies","volume":"14","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104515_bib0035","series-title":"Pharmaceutical Formulation: The Science and Technology of Dosage Forms","first-page":"0","article-title":"Preformulation studies","author":"Jones","year":"2018"},{"key":"10.1016\/j.xphs.2026.104515_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118968","article-title":"An update on microcrystalline cellulose in direct compression: functionality, critical material attributes, and co-processed excipients","volume":"278","author":"Zhao","year":"2022","journal-title":"Carbohydr Polym"},{"issue":"2","key":"10.1016\/j.xphs.2026.104515_bib0037","first-page":"24","article-title":"Using tolerance intervals for evaluation of uniformity of dosage units data in routine batch release","volume":"48","author":"Cholayudth","year":"2024","journal-title":"Pharmaceut Technol"},{"key":"10.1016\/j.xphs.2026.104515_bib0038","unstructured":"United States Pharmacopeia 46. USP <1216>\u201cTablet Friability\u201d, USP <1217>\u201cTablet Breaking Force\u201d, Rockville, MD, USA. Published online 2023."},{"issue":"4","key":"10.1016\/j.xphs.2026.104515_bib0039","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/acs.molpharmaceut.6b01155","article-title":"Impact of gut microbiota-mediated bile acid metabolism on the solubilization capacity of bile salt micelles and drug solubility","volume":"14","author":"Enright","year":"2017","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2026.104515_bib0040","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.xphs.2016.03.024","article-title":"Non-sink dissolution conditions for predicting product quality and In vivo performance of supersaturating drug delivery systems","volume":"105","author":"Sun","year":"2016","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104515_bib0041","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2015.06.038","article-title":"Design of controlled release systems for THEDES\u2014Therapeutic deep eutectic solvents, using supercritical fluid technology","volume":"492","author":"Aroso","year":"2015","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2026.104515_bib0042","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1002\/anie.201207548","article-title":"Low-transition-temperature mixtures (LTTMs): a new generation of designer solvents","volume":"52","author":"Francisco","year":"2013","journal-title":"Angew Chem Int Ed"},{"issue":"28","key":"10.1016\/j.xphs.2026.104515_bib0043","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1007\/s00216-019-02143-z","article-title":"Synthesis and characterization of deep eutectic solvents (five hydrophilic and three hydrophobic), and hydrophobic application for microextraction of environmental water samples","volume":"411","author":"Qu","year":"2019","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.xphs.2026.104515_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2024.108720","article-title":"Unravelling pH\/pKa influence on pH-responsive drug carriers: insights from ibuprofen-silica interactions and comparative analysis with carbon nanotubes, sulfasalazine, and alendronate","volume":"128","author":"Yamin","year":"2024","journal-title":"J Mol Graph Modell"},{"key":"10.1016\/j.xphs.2026.104515_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2020.108988","article-title":"Dextrose equivalence of maltodextrins determines particle morphology development during single sessile droplet drying","volume":"131","author":"Siemons","year":"2020","journal-title":"Food Res Int"},{"issue":"4","key":"10.1016\/j.xphs.2026.104515_bib0046","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1208\/pt040462","article-title":"Physical properties and compact analysis of commonly used direct compression binders","volume":"4","author":"Zhang","year":"2003","journal-title":"AAPS PharmSciTech"},{"issue":"26","key":"10.1016\/j.xphs.2026.104515_bib0047","doi-asserted-by":"crossref","first-page":"14433","DOI":"10.1039\/D1CP00779C","article-title":"Hydration enthalpies of amorphous sucrose, trehalose and maltodextrins and their relationship with heat capacities","volume":"23","author":"Bogdanova","year":"2021","journal-title":"Phys Chem Chem Phys"},{"key":"10.1016\/j.xphs.2026.104515_bib0048","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jfoodeng.2017.02.024","article-title":"Effect of water content on the flowability of hygroscopic powders","volume":"205","author":"Juarez-Enriquez","year":"2017","journal-title":"J Food Eng"},{"key":"10.1016\/j.xphs.2026.104515_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclepro.2022.132336","article-title":"Beyond tablets\u2019 physical characteristics: incorporating environmental sustainability metrics into the selection of lubricants for pharmaceutical tableting","volume":"362","author":"Hadinoto","year":"2022","journal-title":"J Clean Prod"},{"key":"10.1016\/j.xphs.2026.104515_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclepro.2021.126074","article-title":"Selecting optimal pharmaceutical excipient formulation from life cycle assessment perspectives: a case study on ibuprofen tablet formulations","volume":"292","author":"Wang","year":"2021","journal-title":"J Clean Prod"},{"issue":"1","key":"10.1016\/j.xphs.2026.104515_bib0051","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12325-019-01144-9","article-title":"Ibuprofen safety at the golden anniversary: are all NSAIDs the same? A narrative review","volume":"37","author":"Varrassi","year":"2020","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.xphs.2026.104515_bib0052","article-title":"Menthol toxicity: an unusual cause of Coma","volume":"2012","author":"Baibars","year":"2012","journal-title":"Case Rep Med"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:52:24Z","timestamp":1791345144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926003655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0022354926003655"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104515","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral tablets of therapeutic eutectic solvent prepared by spray immobilization into excipient microparticles and direct compression","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104515"}}